Peer Review History
| Original SubmissionMay 17, 2025 |
|---|
|
PONE-D-25-25545 Mapping the Evidence on Outcomes of Childhood Out-of-Home Care: A Scoping Review of Reviews PLOS ONE Dear Dr. Opoku, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. Specifically: ============================== The scoping review of reviews is outside the scope for PLOS ONE. The link you have provided to your protocol is invalid and registration status is not able to be confirmed. ============================== I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Kind regards, Janna Metzler Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 1 |
|
Dear Dr. Opoku, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. -->?> Please submit your revised manuscript by Dec 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mary Diane Clark, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: [This research was funded by the National Institute for Health Research (NIHR156826 - CARELINK Wales - Comprehensive Analysis of Risk factors and outcomes for vulnerable children through LINKed Welsh data), UK, and the Economic and Social Research Council – Administrative Data Research (ESRC-ADR), UK (PhD studentship).]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that there is identifying data in the Supporting Information file <S2 Table. Study characteristics.docx and S3 File. Factors reviewed on various outcome indicators.xlsx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (Name), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 4. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. We note that you have included affiliation numbers 1,2,3 and 4 however only affiliations 1,2 and 3 have authors linked to them. Please amend affiliation 4 to link an author to it or remove if added in error. 4, Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments (if provided): Thank you for submitting your manuscript to PLOS ONE. I was only able to obtain one review but in terms of time, I will act as the second. Most of my concerns are expressed by the one review so please respond to all of those. You have some issue with your time line---in one eligibility you state that the time line is 2003 – 2024. Then in the results you say 1972-2022. Need to clean up the procedure. You have many graphs but then you restate those same items with the number of papers found in the text. The rule is one place or the other---so i suggest stay with the tables and graphs and reduce the text to information not available in the graphs. Finally, the reviewer notes where you need to include all of the procedures in the paper not in the supplemental materials--I agree. The content feels like a sketch rather than a painting --- so it lacks depth. Please expand how you present the data to aid in providing more details. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Greetings Authors, Thank you for taking the time to revise this manuscript. It is my first time reviewing them, so bear with my comments as I help you improve the manuscript before it is ready for publication. This manuscript aims to provide a bird's-eye view of the reviews that were done related to children who experienced OHC. However, please ensure you define OHC. The authors cannot assume the reader knows what it means, especially in the PLOS ONE journal, which covers a wide range of research. Now to the substantial part of the manuscript, acronyming the domains carries the risk of overloading the reader’s cognitive abilities, as they have to refresh what each domain stands for. I would recommend the authors to write the factors out instead of using the acronym, such as health and emotional well-being, instead of HEW. Regarding the domains, how did your team determine that the review falls under that factor? It will also be helpful to readers to know the process of coding domains to reviews, because Figure 1 initially showed more factors than the total number of reviews. The footnote does not seem sufficient to describe how the authors determined which factors to assign to the review. That will need to be clear in the method section. Table 1 should list all indicators rather than selecting example ones; this will help readers orient themselves before reading the results, rather than realizing there are many indicators when they reach Figure 3. Why do Figures 4 & 5 show the inverse list of factors? Keep in mind to reduce the cognitive overload for the readers to improve the reader’s appreciation of your work. The axis is also inverse too. Pick one format and stick with it throughout all charts to minimize the cognitive overload. Checking out the protocol in OSF, why is the information in OSF not included in the manuscript, such as the background and research questions? The authors should not assume that the readers will take the time to review the protocol in OSF. Again, to minimize the cognitive overload, the authors should have this information in the manuscript. There should be a paragraph at the end of the results synthesizing the findings. What does the result mean to the broader audience? How do they answer your research questions? The discussion recapped some of the results but needs to make a more concrete effort to connect them to the broader context of OHC and to offer recommendations for potential future research. Regarding on the writing and mechanism, it is mostly in a good shape except for few typos and paragraph formatting. The authors will need to proof them before the next submission since PLOS One does not have a copyeditor who could clean up the manuscript before publishing. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Scott Cohen ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Mapping the Evidence on Outcomes of Childhood Out-of-Home Care: A Scoping Review of Reviews PONE-D-25-25545R2 Dear Dr. Opoku, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mary Diane Clark, PhD Academic Editor PLOS One Additional Editor Comments (optional): Thank you for the changes. The solve the issues noted earlier. I do have one comment/issue. Some of your tables are not publication perfect. I am asking the journal to check and make that decision. I think the tables are great but don't seem to be the correct format for printing. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Greetings authors, Thank you for revising the manuscript. The readability has dramatically improved as I read it. I appreciated the Tables, as they helped me understand your findings and discussion. It made your review more straightforward and to the point for future research to identify which research areas warrant more urgent attention, such as identity and civic participation. I have not identified any errors and believe it is ready for publication. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Scott Cohen ********** |
| Formally Accepted |
|
PONE-D-25-25545R2 PLOS One Dear Dr. Opoku, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mary Diane Clark Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .